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        Introduction 
  Telomeres are the repetitive DNA sequences and specialized 
proteins that cap the ends of linear eukaryotic chromosomes 
and protect them from degradation or fusion by DNA repair 
processes. Telomere integrity and length maintenance are es-
sential for prolonged cell proliferation and are thought to play 
important roles in suppressing aging and cancer (  Blackburn, 
2000  ;   Rodier et al., 2005  ). 
  Telomere length is generally maintained by telomerase, 
a reverse transcription that adds telomeric DNA repeats to 
chromo  some ends. Telomere length homeostasis also de-
pends on proteins that act at telomeres in cis to control 
the recruitment or access of telomerase (  Smogorzewska and 
de Lange, 2004  ). Most human cells do not express telomerase. 
Because DNA replication machineries cannot fully copy DNA 
3     ends, such cells lose telomeric DNA with each S phase. 
When telomeres become critically short, the cells enter a 
permanent growth-arrested state termed senescence (  Rodier 
et al., 2005  ). Both telomerase-expressing and telomerase-
negative cells use a host of proteins to ensure a proper protec-
tive telomeric structure. 
  The precise structure of mammalian telomeres is not 
known. However, a   “  t-loop  ”   structure, in which the 3     over-
hang loops back and invades the telomeric DNA duplex, has 
been inferred by electron microscopy and biochemical experi-
ments (  Griffi  th et al., 1999  ). The t-loop model explains how 
telomeric ends are protected from recognition by DNA repair 
machineries. This protection is sometimes termed capping. 
Telomeres can become uncapped when critically short, pre-
sumably too short to form a t-loop, or when certain telomeric 
proteins are defective. 
  Several telomere-associated proteins are known to be im-
portant for telomere length regulation and capping ( Smogorzewska 
and de Lange, 2004  ;   Rodier et al., 2005  ). These include the direct 
telomeric DNA-binding proteins telomeric repeat binding factor 1 
(TRF1), TRF2, and protector of telomeres 1 (POT1), proteins that 
associate with these telomeric DNA binding actors (e.g., TRF1-
interacting protein 2 [TIN2], hRap1, and tankyrases), and a vari-
ety of proteins involved in other processes, such as DNA repair 
T
elomeres are maintained by three DNA-binding 
proteins (telomeric repeat binding factor 1 [TRF1], 
TRF2, and protector of telomeres 1 [POT1]) and sev-
eral associated factors. One factor, TRF1-interacting pro-
tein 2 (TIN2), binds TRF1 and TRF2 directly and POT1 
indirectly. Along with two other proteins, TPP1 and hRap1, 
these form a soluble complex that may be the core telo-
mere maintenance complex. It is not clear whether sub-
complexes also exist in vivo. We provide evidence for two 
TIN2 subcomplexes with distinct functions in human cells. 
We isolated these two TIN2 subcomplexes from nuclear 
lysates of unperturbed cells and cells expressing TIN2 
mutants TIN2-13 and TIN2-15C, which cannot bind TRF2 
or TRF1, respectively. In cells with wild-type p53 function, 
TIN2-15C was more potent than TIN2-13 in causing 
telomere uncapping and eventual growth arrest. In cells 
lacking p53 function, TIN2-15C was more potent than 
TIN2-13 in causing telomere dysfunction and cell death. 
Our ﬁ  ndings suggest that distinct TIN2 complexes exist 
and that TIN2-15C  –  sensitive subcomplexes are particu-
larly important for cell survival in the absence of func-
tional p53.
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  Results 
  TIN2 depletion disrupts TRF1 and TRF2 
and causes cell death in the absence of 
p53 function 
  To understand the effects of TIN2 on cell fate and telomeric 
complex integrity, we used RNAi to ablate TIN2 expression. 
We expressed short hairpin RNAs (shRNAs;   Brummelkamp 
et al., 2002  ) complementary to three regions of the TIN2 mRNA 
(T2i-1, T2i-2, and T2i-3) in HT1080 human fi  brosarcoma cells. 
Two of the shRNAs, T2i-2 and T2i-3, reduced TIN2 protein lev-
els by 70  –  80% (  Fig. 1 a  ). T2i-2 and T2i-3 (not depicted) also 
reduced TRF1 and TRF2 protein levels (  Fig. 1 b  ), which is con-
sistent with the reported degradation of TRF1 upon removal 
from telomeres (  Chang et al., 2003  ). T2i-2 also reduced focal 
immunostaining, which is indicative of telomeric localization 
of TIN2, TRF1, and TRF2 (Fig. S1, available at http://www.jcb
.org/cgi/content/full/jcb.200710028/DC1). Thus, loss of TIN2 
completely disrupted telomeres, as determined by the loss of 
TRF1 and TRF2 protein levels and telomeric occupancy. 
  After the loss of telomeric TIN2, TRF1, and TRF2, T2i-2 
and T2i-3 induced caspase-dependent cell death, which is in-
dicative of apoptosis (  Fig. 1 c  ). Cell death was not observed 
when cells expressed an insertless vector, a nonspecifi  c shRNA 
or T2i-1, which did not reduce TIN2 expression (  Fig. 1, a and c  ). 
T2i-2 also induced apoptosis in primary human fi  broblasts 
(strains HCA2 and WI-38;   Fig. 1 d  ). Strikingly, inactivation of 
p53 by GSE-22, a short peptide that disrupts p53 tetrameriza-
tion and causes accumulation of monomeric p53 in these cells 
(  Gudkov et al., 1993  ), failed to rescue WI-38 cells from T2i-2  –
  induced apoptosis (  Fig. 1 d  ). Loss of p53 activity was confi  rmed 
by the absence of detectable p21 immunostaining and enhanced 
p53 immunostaining in x-irradiated GSE-22  –  expressing but not 
control cells (  Fig. 1 e  ). Thus, TIN2 was essential for TRF1 and 
TRF2 stability and occupancy at telomeres as well as the viabil-
ity of normal and tumor-derived human cells, regardless of p53 
status. This result suggests that the loss of TIN2 promotes a se-
riously aberrant telomeric structure that induces cell death even 
in the absence of p53, which is similar to the effects of telomere 
disruption caused by expression of a mutant telomerase tem-
plate RNA (  Li et al., 2004  ). 
  TIN2 subcomplexes are formed in cells 
  To gain insight into physiologically relevant TIN2 complexes, 
we prepared nuclear extracts from HeLa cells using a modifi  ed 
Dignam protocol (  Dignam et al., 1983  ). The majority of endog-
enous TRF1 is extracted by this high salt (  >  0.3 M KCl) method 
(  Okabe et al., 2004  ). To detect TIN2 complexes, the extracts 
were dialyzed into buffer approximating physiological ionic 
strength and then fractionated by size-exclusion chromatogra-
phy. The resulting fractions were analyzed by Western blotting 
(  Fig. 2, a and b  ). 
  We detected TIN2 across a broad range of molecular mass, 
from   ≤  1.5 MD to     100 kD in fractions 13  –  33 (  Fig. 2 a  ). TRF1 
eluted in two distinct peaks, coeluting with TIN2 in fractions 15 – 17 
and 27  –  33. All six telomere-associated proteins (TRF1, TIN2, 
TRF2, hRap1, POT1, and TPP1) cofractionated in fractions 15 – 17, 
and recombination. Of the direct DNA-binding proteins, TRF1 
binds double-stranded telomeric DNA and is an important regula-
tor of telomere length (  van Steensel and de Lange, 1997  ). In con-
trast, TRF2, which also binds double-stranded telomeric DNA, is 
more important for telomere capping (  van Steensel et al., 1998  ; 
  Karlseder et al., 1999  ;   Smogorzewska and De Lange, 2002  ). 
POT1 binds the single-stranded 3   overhang and is likely a terminal 
regulator of telomere length and end protection (  Baumann and 
Cech, 2001  ). 
  TIN2 is an important telomere-associated protein because 
it binds both TRF1 (  Kim et al., 1999  ) and TRF2 (  Kim et al., 
2004  ;   Liu et al., 2004a  ;   Ye et al., 2004a  ) and indirectly interacts 
with POT1 via the intermediary protein TPP1 (also termed 
pTOP [  Liu et al., 2004b  ], PIP1 [  Ye et al., 2004b  ], and TINT1 
[  Houghtaling et al., 2004]  ). TIN2 participates in the regulation 
of telomere length through its interactions with TRF1 (  Kim et al., 
1999  ) and TPP1 (  Houghtaling et al., 2004  ;   Liu et al., 2004b  ;   
Ye et al., 2004b  ). In addition, TIN2 appears to be a critical com-
ponent in forming telomere complexes that function in end pro-
tection (  Kim et al., 2004  ). 
  The functions of the three telomeric DNA-binding pro-
teins (TRF1, TRF2, and POT1) are very likely coordinated. 
Perturbations of either TRF1 or TRF2 or their associated pro-
teins POT1, hRap1, or TIN2 influence both telomere length 
and capping (  van Steensel and de Lange, 1997  ;   Kim et al., 
1999, 2004  ;   Loayza and De Lange, 2003  ;   Iwano et al., 2004  ; 
  Yang et al., 2005  ). These observations suggest that TRF1, 
TRF2, POT1, and TIN2 may function in the same pathway. 
Consistent with this idea, six proteins copurifi  ed in a large 
molecular weight complex (  Liu et al., 2004a  ;   Ye et al., 2004a  ; 
  O  ’  Connor et al., 2006  ). This complex may be the core molecu-
lar machinery that regulates mammalian telomeres. However, 
gel fi  ltration identifi  ed a TRF2  –  hRap1 complex that also con-
tains TIN2 and POT1 but not TRF1 (  Ye et al., 2004a  ). Further-
more, when TRF1 is removed from telomeres, TIN2 and TPP1 
remain at telomeres via increased association with TRF2 
(  Houghtaling et al., 2004  ). And, although POT1 was shown to 
be associated with TRF1 (  Loayza and De Lange, 2003  ), POT1 
and TRF2 also form a complex with telomeric DNA, and POT1 
overexpression protects against loss of telomeric single-stranded 
DNA caused by expression of a dominant-negative TRF2 
(DN-TRF2;  Yang et al., 2005  ). Thus, there may be distinct telo-
meric complexes that participate in maintaining telomere length 
and capping. 
  It is not yet clear whether there is a single TIN2 complex 
that always contains TRF1, TRF2, and TPP1/POT1 and their 
interacting proteins or whether TIN2 forms multiple com-
plexes, some of which contain TRF1, whereas others contain 
TRF2 (  Houghtaling et al., 2004  ;   Kim et al., 2004  ;   Ye et al., 
2004a  ). Furthermore, although it is hypothesized that telo-
meric complexes respond to telomere shortening, it is not 
known which telomere complexes are important for telomere 
capping, cellular senescence, and cell death. Here, we fi  nd that 
at least two major TIN2 complexes can be identifi  ed by immuno-
precipitation and gel fi  ltration of cell lysates and that one of 
these is crucial for cellular senescence and cell survival in the 
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  O  ’  Connor et al., 2006  ) in which TPP1 was only marginally 
detectable. Our one-step protocol, in contrast, showed that TPP1 
was a prominent component of complex B. We quantifi  ed the 
  signals from the Western blots to illustrate the elution profi  les of 
the six telomeric proteins (  Fig. 2 b  ). 
  Under our experimental conditions, we observed an addi-
tional telomere protein complex (complex A) containing sig-
nifi  cant amounts of TIN2 and TRF1 in the lower molecular 
which is consistent with the large complex termed shelterin 
(  de Lange, 2005  ) and referred to here as complex C. We also ob-
served a protein complex containing TIN2, TRF2, hRap1, POT1, 
and TPP1 but lacking TRF1 (  Fig. 2 a  , fractions 19  –  23), which 
is consistent with previous studies (  Ye et al., 2004a  ;   O  ’  Connor 
et al., 2006  ). We term this complex complex B. The complex B 
we detected here differs somewhat from that previously reported 
(termed fraction 1, isolated by a two-step chromatographic  protocol; 
  Figure 1.       Effects of TIN2 ablation on TRF1, TRF2, and cell viability.   (a) RNAi reduces TIN2 expression. HT1080 cells were transiently transfected with 
pSuper vectors expressing shRNAs corresponding to a nonexpressed (nonspeciﬁ  c [N/S]) mRNA or one of three distinct regions in the TIN2 mRNA (T2i-1, 
T2i-2, and T2i-3) as described in Materials and methods. Transfection efﬁ  ciency varied from 60 to 70%. Cell lysates were analyzed 48 h later by Western 
blotting for TIN2 expression with     -tubulin used as a loading control. TIN2 protein levels were reduced to 23 and 24% of control levels by T2i-2 and T2i-3, 
respectively. Control cells expressed the N/S shRNA. (b)     TIN2 reduction decreases TRF1 and TRF2 protein expression. Lysates from HT1080 cells trans-
fected with the N/S (control) or T2i-2 pSuper vectors described above were analyzed for TIN2, TRF1, TRF2, and     -tubulin by Western blotting. The protein 
band intensities were analyzed as described in panel a. TIN2 and TRF2 protein levels were reduced to 16 and 13%, respectively, of control levels. 
(c) TIN2 reduction induces apoptosis in human tumor cells. HT1080 cells were transiently transfected with pSuper vectors containing no insert (vector) or N/S 
(control), T2i-1, T2i-2, or T2i-3 shRNAs and analyzed 48 h later for apoptosis as described in Materials and methods. Transfection efﬁ  ciency was 60  –  70%. 
Where indicated, the caspase inhibitor ZVAD (100   μ  M) was added 8 h after transfection. 200 cells were analyzed for apoptosis in three independent 
experiments. Error bars represent the standard deviation. (d) TIN2 reduction induces apoptosis in normal human cells. Normal human ﬁ  broblasts (HCA2 
and WI-38) were transiently cotransfected with pSuper vectors containing no insert (vector) or T2i-1 or T2i-2 shRNAs, and a lenti-GFP vector at a ratio of 
10:1. 48 h later, GFP positive cells were analyzed for apoptosis as described in Materials and methods. Where indicated, WI-38 cells were ﬁ  rst infected 
with a retrovirus expressing GSE-22, selected, and then infected with the pSuper and GFP vectors. 200 cells were analyzed in three experiments. Error bars 
represent the standard deviation. (e) GSE-22 inactivates p53 activity in normal cells. WI38 cells were infected with a retrovirus expressing GSE-22 or an 
insertless virus, selected, plated, and irradiated with a 10-Gy x ray. The cells were ﬁ  xed 19 h later and immunostained for p21 and p53. Bars,     10   μ  M.     JCB • VOLUME 181 • NUMBER 3 • 2008  450
  Figure 2.       TIN2-mediated complexes.   (a) Endogenous TIN2 complexes in HeLa nuclear lysate. Telomeric proteins in HeLa nuclear extracts (2. 5 ml) were 
fractionated on a Sepharcryl S-300 HR column and immunobloted for the indicated proteins. 20   μ  l aliquots of the indicated fractions were loaded. Eluting 
fractions were collected from the column after the void volume (No. 13). Molecular sizes indicated were derived from a standard curve based on the 
elution standards as described in Materials and methods. (b) Western blotting signals in   Fig. 2 a   were quantiﬁ  ed with the Multi-Gauge program. Relative 451 TELOMERE COMPLEXES AND CELL SURVIVAL   •   Kim et al.
  V5 antibodies precipitated a major complex of POT1, 
TPP1, TIN2, TRF2, and hRap1 (complex B) regardless of whether 
TRF1 was overexpressed and a minor complex containing TRF1, 
TIN2, TPP1, POT1, TRF2, and hRap1 (complex C). Because 
POT1 does not interact directly with TRF2 (  Loayza and De 
Lange, 2003  ), this result suggests that POT1/TPP1 (  Xin et al., 
2007  ) forms a more stable complex with TIN2  –  TRF2/hRap1 
than  with  TIN2 – TRF1. 
  When Flag-TIN2 was the precipitating protein, Flag anti-
bodies (  Fig. 2 c  , lanes 6 and 7) precipitated more complex B in 
the absence of overexpressed TRF1 than in its presence. This 
result suggests that TRF1 and TRF2 compete with TIN2 to form 
two separable complexes, A and B. In addition, we detected 
a small amount of complex C in lysates from cells that over-
expressed TRF1 and TIN2. In the Discussion, we propose possible 
explanations for the relatively minor abundance of complex C 
after immunoprecipitation compared with nuclear extraction. 
  Together, the fractionation and immunoprecipitation data 
indicate the existence of distinct TIN2 complexes in cells. For 
simplicity, we term these complexes as follows: TRF1  –  TIN2, 
complex A; TIN2 – TRF2/hRap1 – TPP1/POT1, complex B; TRF1 – 
TIN2  –  TRF2/hRap1  –  TPP1/POT1, complex C (  Fig. 2 d  ). 
  TIN2 mutants have distinct effects on 
TIN2 complexes 
  TIN2-13 and TIN2-15C are TIN2 truncation mutants with dif-
ferent binding capabilities (  Fig. 3 a  ). TIN2-15C lacks TRF1 
binding (  Kim et al., 1999  ). It retains the TRF2-binding domain 
but interacts less strongly than wild-type TIN2 with TRF2 (  Kim 
et al., 2004  ). Immunoprecipitation of lysates from cells express-
ing epitope-tagged TIN2-15C and POT1 showed that TIN2-15C 
retains TPP1/POT1 binding (  Fig. 3 b  ). Reciprocally, TIN2-13 
retains TRF1 binding (  Kim et al., 1999  ) but lacks TRF2 (  Kim 
et al., 2004  ) and TPP1/POT1 (  Ye et al., 2004b  ) binding. We used 
these mutants to identify TIN2 complexes in cells and deter-
mine their role in the cell death caused by complete loss of TIN2 
in p53-defi  cient cells. 
 We  fi rst tested the effects of TIN2 mutants on complex A, 
B, and C formation. Based on their composition (  Fig. 2  ), we 
predicted that TIN2-13, which lacks TPP1 and TRF2 binding 
(  Liu et al., 2004b  ;   Ye et al., 2004b  ), would perturb complexes A 
and C, whereas TIN2-15C, which lacks TRF1 binding, would 
perturb complexes B and C (  Fig. 3 a  ). We expressed V5-POT1 
plus wild-type TIN2, TIN2-13, or TIN2-15C in HT1080 cells 
and immunoprecipitated cell lysates us)ing V5 antibodies (  Fig. 3 c  , 
lanes 5  –  8). 
  When TIN2-13 was expressed, V5 antibodies did not pre-
cipitate TIN2-13, and the level of endogenous TIN2 was not al-
tered in the precipitate (note that anti-V5 precipitated less POT1 
in   Fig. 3 c  , lane 6; compare lanes 6 and 7). This result indicates 
that V5-POT1 mainly precipitated TIN2 B complexes and that 
mass range (  Fig. 2 a  , fractions 27  –  33). Fractions 27  –  31 also 
contained low levels of a TPP1  –  POT1 complex, as previously 
reported (  Xin et al., 2007  ). However, in contrast to our fi  ndings 
(  Fig. 2 a  ), these studies (  Liu et al., 2004a  ;   Ye et al., 2004a  ; 
  O  ’  Connor et al., 2006  ) did not detect complex A in the same 
molecular mass range, possibly because of the lower salt used 
for extraction or different gel-fi  ltration conditions. Complex A 
does not appear to arise from larger complexes (e.g., complex C) 
as a consequence of high salt extraction because there is no evi-
dence of dissociated or degraded monomeric proteins (TRF2, 
POT1, TPP1, and hRap1) in the low molecular weight fractions 
(  Fig. 2a  , fractions 35  –  49). This result is most consistent with a 
bona fi  de TRF1  –  TIN2 complex (complex A) existing in vivo. 
As expected, we detected degraded TIN2 in fractions 57  –  65. 
We confirmed the absence of monomeric proteins (and the 
presence of degraded protein) using twice the amount of sam-
ple and a different gel fi  ltration column (Superdex S-200, 600  –
  10 kD) that is better at fractionating low  –  molecular weight 
proteins (Fig. S2 a, available at http://www.jcb.org/cgi/content/
full/jcb.200710028/DC1). This fractionation showed that low 
molecular ranges (Fig. S2 a, fractions 29  –  55) contained only 
degradation products of TIN2 and TRF1. TRF1 is degraded 
when dissociated from telomeres (  Chang et al., 2003  ). More-
over, the high salt nuclear extracts contained   >  90% of the TRF1, 
TRF2, and TIN2, which suggests that most of these proteins 
were released from telomeres (Fig. S2 b). These results suggest 
that complex A (TRF1  –  TIN2) might be degraded upon disso-
ciation from telomeres by high salt (0.5 M); in lower salt (0.3  –
  0.4 M), this complex is not released from telomeres and is 
therefore not detected. 
  Our chromatographic results are consistent with the exis-
tence of three heteromeric complexes (complexes A, B, and C), 
although, taken alone, the results are also consistent with each 
of the proteins being assembled into homomeric complexes of 
approximately equal size. 
  To discriminate between these possibilities and more 
directly probe telomeric protein assemblies without high salt 
extraction, we overexpressed epitope-tagged POT1, TIN2, or 
TRF1 (V5-tagged POT1, Flag-tagged TIN2, and HA-tagged 
TRF1) in HT1080 cells. We prepared cell lysates using physio-
logical ionic strength (0.15 M NaCl), which does not liberate 
endogenous TRF1 and TIN2 as determined by Western blotting 
(unpublished data). We expected anti-V5 to immunoprecipitate 
complexes B and C, anti-HA to precipitate complexes A and C, 
and anti-Flag to precipitate all three complexes. 
 The major complex precipitated by HA antibodies ( Fig. 2 c , 
lanes 10 and 11) was complex A (TRF1  –  TIN2). A minor com-
plex containing TRF1, TIN2, and TPP1 was also detectable. 
These fi  ndings suggest that most TRF1 proteins formed a com-
plex with TIN2 under the immunoprecipitation conditions of RIPA 
buffer and physiological salt. 
band intensities for each protein were plotted. (c) TIN2-complexes. We prepared lysates from HT1080 cells that transiently expressed V5-tagged POT1 
and stably expressed Flag-TIN2 (lanes 2, 4, 6, and 8) or HA-TRF1 (lanes 1 and 10), or both Flag-TIN2 and HA-TRF1 (lanes 3, 5, 7, 9, and 11;   Kim et al., 
1999  ). We isolated TIN2 complexes using Flag, V5, and HA antibodies and analyzed the lysates (10%, input) and immunoprecipitates (IP) for the indi-
cated proteins by Western blotting (WB). (d) Proposed TIN2 complexes. Complex A, TRF1  –  TIN2; complex B, TIN2  –  TRF2/hRap1  –  TPP1/POT1; complex C, 
TRF1  –  TIN2  –  TRF2/hRap1  –  TPP1/POT1.     
 JCB • VOLUME 181 • NUMBER 3 • 2008  452
ing that TIN2-15C inhibits the TIN2  –  TRF2 interaction. This 
result suggests that TIN2-15C disrupts complex B formation, as 
predicted, and is consistent with the fi  nding that TIN2-15C re-
duces TRF2 stability in cells and dissociates TRF2 from telo-
meres (  Kim et al., 2004  ). TIN2-15C or DN-TRF2 slightly 
reduced (84 and 89%, respectively) the length of the 3     single-
stranded telomeric overhang in normal HCA2 cells (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200710028/DC1). 
TIN2-13 does not disrupt complex B, as predicted. This result 
also confi  rms the inability of TIN2-13 to interact with TRF2 
(  Kim et al., 2004  ) and TPP1/POT1 (  Ye et al., 2004b  ). 
  In contrast, when TIN2-15C was expressed, V5 antibodies 
precipitated TIN2-15C, and the presence of TIN2-15C reduced 
the level of endogenous TIN2 in the precipitate (  Fig. 3 c  , lane 8). 
Furthermore, TIN2-15C expression reduced the level of TRF2 
in the precipitate (  Fig. 3 c  , compare lanes 6 and 8), indicat-
  Figure 3.       TIN2 complexes disrupted by TIN2 mutants.   (a) TIN2 deletion mutants. Wild type TIN2 (aa 1  –  354) showing N-terminal (N-term), TRF1-inter-
action (TRF1-Int), and C-terminal (C-term) domains, and deletion mutants TIN2-13 (aa 180  –  354) and TIN2-15C (aa 1  –  257). (b) Interaction of TIN2-15C 
with POT1/TPP1. Lysates from HT1080 cells that transiently expressed Myc-TIN2-15C, V5-POT1, and HA-TRF1 were precipitated using anti-Myc or V5 
antibodies. Unprecipitated lysates (10%) and the immune precipitates (IP) were analyzed for POT1-V5, TIN2-15C, TRF2, and HA-TRF1 by Western blotting (WB). 
(c) TIN2  –  TRF2  –  POT1 complexes disrupted by TIN2-15C but not TIN2-13. Lysates from HT1080 cells transiently expressing wild-type TIN2 (WT-TIN2), control 
vector, TIN2-13, or TIN2-15C and V5-POT1 were immunoprecipitated (IP) by anti-V5. The lysates (15%, input) and immune precipitates were analyzed for 
TIN2, V5, TRF2, and     -tubulin by Western blotting (WB; lanes 1  –  8). The band indicated by an asterisk is a degraded WT-TIN2 product. (d) TRF1  –  TIN2 
complexes disrupted by TIN2-13 but not TIN2-15C. Lysates from HT1080 cells transiently expressing WT-TIN2, TIN2-13, TIN2-15C, and HA-TRF1 were 
immunoprecipitated (IP) by anti-HA. The lysates (15%, input) and precipitates were analyzed for TIN2, TRF2, HA, and     -tubulin by Western blotting (WB; 
lanes 9  –  18). The precipitating heavy chain is indicated (IgG). The band indicated by an asterisk is a degraded WT-TIN2 product.     453 TELOMERE COMPLEXES AND CELL SURVIVAL   •   Kim et al.
meres (  Zou et al., 2004  ), similar to those in late-generation 
telomerase-defi  cient mice. Moreover, because HCA2 cells ex-
press low levels of p16 (unpublished data), which inhibits the 
proliferation of cells that lack p53 function, p53 inactivation 
causes senescent HCA2 cells to resume proliferation, as re-
ported for other low p16-expressing human fi  broblast strains 
(  Beausejour et al., 2003  ). We measured the ability of senescent 
HCA2 cells to form colonies after p53 inactivation and disrup-
tion of telomere complexes by TIN2 mutants. We compared the 
effects of TIN2 mutants to the effect of DN-TRF2, which un-
caps telomeres and induces p53-dependent cell death (  Fig. 4 b  ; 
  Karlseder et al., 1999  ). 
  Senescent cells readily formed colonies upon expression 
of GSE-22, as expected (  Beausejour et al., 2003  ). Subsequent 
expression of GFP (control), TIN2-13, or DN-TRF2 had no 
effect on colony formation after 12 (  Fig. 4 b  ) or 30 d (not de-
picted). In contrast, subsequent expression of TIN2-15C initially 
had no effect on cell proliferation (for 3  –  10 d; not depicted) but 
then dramatically reduced colony formation. The differences 
between TIN2-15C and TIN2-13 or DN-TRF2 in supporting 
colony formation could not be explained by differences in pro-
tein expression levels because TIN2-13 and DN-TRF2 were ex-
pressed more robustly than TIN2-15C (  Fig. 4 c  ). 
  Together, these fi  ndings suggest that p53-dependent cell 
growth requires both TIN2 A and B complexes. In contrast, the 
growth of cells that lack p53 function does not require TIN2 A 
complexes, which are disrupted by TIN2-13 (  Fig. 3  ), but does 
require TIN2 B complexes, which are disrupted by TIN2-15C 
(  Fig. 3  ). DN-TRF2, which lacks the TRF2 DNA-binding do-
main and causes p53-dependent cell death (  Karlseder et al., 
1999  ), is clearly not equivalent to TIN2-15C in biological activ-
ity, possibly because it does not affect POT1 function in com-
plex B (see Discussion). 
 We  confi  rmed the selective sensitivity of p53-defi  cient 
cells to TIN2-15C using several human cancer cell lines. These 
included HT1080 fi  brosarcoma cells (which were reported to 
undergo no cell death upon expression of DN-TRF2;   Karlseder 
et al., 1999  ), MDA-MB-231, and MDA-MB-157 breast cancer 
cells, and PPC-1 prostate cancer cells. We used a transfected a 
pIRES2-eGFP vector (  Kim et al., 2004  ) and measured apoptotic 
cell death. TIN2-15C expression induced signifi  cant cell death 
within 48 h in all these p53-defi  cient cancer cells (  Fig. 4 d  ), 
whereas TIN2-13 was two- to eightfold less effective, depend-
ing on the cell line (  Fig. 4 d  ). Compared with normal cells in 
which p53 was inactivated by GSE-22, apoptosis was more 
robust in the cancer cells, being evident as early as 18 h after 
transfection, presumably because cancer cells harbor multiple 
mutations that disrupt cell growth and survival pathways. The 
TIN2 mutants caused much less cell death in p53-positive can-
cer cells (MCF-7 and LN-Cap;   Fig. 4d  ). In all cases, TIN2-15C, 
and to a lesser extent TIN2-13, caused substantial cell death in 
p53-defi  cient cells (  Fig. 4 d  ) but very little cell death in cells 
with wild-type p53 (  Fig. 4 a  ). 
  Normal cells responded to TIN2-15C by undergoing senes-
cence. TIN2-15C, much more than TIN2-13, retarded cell prolifer-
ation (  Fig. 5 a  ) and induced senescence-associated    -galactosidase 
(  Fig. 5 b  ). Both mutants also induced 53BP1/   H2AX  foci 
Inactivation of TRF2 by DN-TRF2 or TRF2 deletion reduced 
or slightly increased the 3     overhang length in cells that were 
defi  cient in p53 or in both p53 and ligase IV (  van Steensel 
et al., 1998  ;   Celli and de Lange, 2005  ). Thus, TIN2-15C and 
DN-TRF2 may have similar effects on 3     overhang length regu-
lation in normal cells. 
 We also expressed HA-TRF1 plus wild-type TIN2, TIN2-13, 
or TIN2-15C and immunoprecipitated lysates using HA anti-
bodies (  Fig. 3 d  , lanes 13  –  16). TIN2-13 reduced the binding of 
endogenous TIN2 to HA-TRF1 (  Fig. 3 d  , compare lanes 13 and 
15), but TIN2-15C did not disrupt this interaction (compare 
lanes 13 and 16). Thus, as predicted, TIN2-13 disrupted TRF1  –
  TIN2 complexes (complex A) but TIN2-15C did not. 
  We conclude that the TIN2 mutants TIN2-13 and TIN2-
15C disrupt different TIN2 complexes, at least by immuno-
precipitation analysis, and thus favor the formation of different 
telomeric complexes when expressed in cells. 
  Effects of TIN2 mutants in cells 
  To determine the biological effects of the TIN2 complexes, we 
expressed GFP (control), TIN2-13, or TIN2-15C in primary 
human fi  broblasts (strain HCA2). We also analyzed these cells 
after p53 inactivation, achieved by expressing GSE-22 (  Gudkov 
et al., 1993  ) or a p53 shRNA (sh-p53). 
 We  fi  rst tested presenescent or replicatively senescent 
cells with or without p53 inactivation and measured apoptotic 
cell death using a sensitive cumulative assay (  Fig. 4 a  ;   Goldstein 
et al., 2005  ). We defi  ne presenescent cultures as those that retain 
  >  70% of their replicative life span and thus contain cells with 
mostly long, functional telomeres. In contrast to the robust cell 
death caused by complete loss of TIN2 (  Fig. 1, c and d  ), TIN2-13 
or TIN2-15C caused little or no cell death when expressed in 
presenescent or senescent cells with normal p53 function ( Fig. 4 a ). 
However, when p53 was inactivated, the fraction of apoptotic 
cells increased in both cell populations (  Fig. 4 a  ). Notably, co-
expression of TIN2-13 and GSE-22 elevated apoptosis only 
about twofold above the levels in control cells (expressing GFP 
and GSE-22), whereas coexpression of TIN2-15C and GSE-22 
increased cell death 8- to 10-fold above control levels (  Fig. 4 a  ). 
Coexpression of TIN2 mutants with sh-p53 gave very similar 
results (  Fig. 4 a  ). These fi  ndings suggest that disruption of the 
TIN2 – TRF2  or  TIN2 – TPP1/POT1  interaction  (by  TIN2-15C) 
has more severe consequences for cell survival than disruption 
of the TRF1  –  TIN2 interaction (by TIN2-13). They also indicate 
that disruption of telomeric complexes B and C (by TIN2-15C) 
is more deleterious than disruption of complex A and C (by 
TIN2-13). Moreover, the cell death caused by disrupting these 
complexes does not require p53 function. 
  Late generation mice lacking both telomerase and p53 
progress very few generations relative to telomerase defi  ciency 
alone, which suggests the existence of a telomere-dependent 
cell death pathway that does not require p53 (  Chin et al., 1999  ). 
To further test the idea that disruption of different telomeric 
complexes differentially affects the survival of cells that lack 
p53 function, we used lentiviral vectors to express TIN2 mu-
tants and GSE-22 in replicatively senescent HCA2 fi  broblasts. 
These senescent cells have several short, dysfunctional telo-JCB • VOLUME 181 • NUMBER 3 • 2008  454
already have several telomeric 53BP1 foci. In all cases, TIN2-15C 
induced many more 53BP1 foci than TIN2-13 (  Fig. 5 c  ), which 
suggests that TIN2-15C is more potent than TIN2-13 at uncap-
ping telomeres. These results also suggest that B complexes 
are more important than A complexes for protecting cells from 
cell death. 
(  d  ’  Adda di Fagagna et al., 2003  ;   Takai et al., 2003  ). Most of 
these foci (60  –  90%) colocalized with a telomeric DNA probe 
(Fig. S4, available at http://www.jcb.org/cgi/content/full/jcb
.200710028/DC1), indicating that they marked dysfunctional 
telomeres. The TIN2 mutants induced 53BP1 foci in pre-
senescent cells as well as replicatively senescent cells, which 
  Figure 4.       Effects of TIN2 mutants in presenes-
cent and senescent cells.   (a) Cell death caused 
by TIN2-15C in presenescent cells. Where 
indicated, presenescent (P) HCA2 cells were 
ﬁ  rst infected with a retrovirus expressing GSE-22 
and a lentivirus expressing sh-p53 and selected 
for 2  –  3 d. Cells were then infected with lenti-
viruses expressing GFP, TIN2-13, or TIN2-15C. 
Where indicated, senescent (S) HCA2 cells 
were ﬁ  rst infected with lentiviruses expressing 
GFP, TIN2-13, or TIN2-15C and then infected 
with a lentivirus expressing GSE-22. Cells were 
scored for apoptotic death by assessing release 
of cytochrome   c   from mitochondria as de-
scribed previously (  Goldstein et al., 2005  ). 
300 cells were scored in two or three inde-
pendent experiments. Error bars represent 
the standard deviation. (b) Effects of TIN2-15C 
on senescent cells reactivated by GSE-22. 5   ×   
10 
4   senescent HCA2 cells were infected with 
lentiviruses expressing GFP (control), TIN2-13, 
TIN2-15C, or DN-TRF2 and then infected with 
lenti-GSE-22. Colonies were stained at the indi-
cated days after infection. (c) Expression levels 
of TIN2 mutants and DN-TRF2. Lysates from 
presenescent cells infected with the indicated 
lentiviruses were analyzed for TIN2 and TRF2 by 
Western blotting (WB). (d) Cell death induced 
by TIN2-15C in p53-positive and -negative 
cancer cells. p53-positive (breast MCF-7 and 
prostate LN-Cap) cancer cells and p53-negative 
(breast MDA-MB-231 and MDA-MB-157, pros-
tate PPC-1, and ﬁ  brosarcoma HT1080) cancer 
cells were transiently transfected with pIRES2-
eGFP vectors expressing no insert (vector), 
TIN2-13, or TIN2-15C. 48 h later, the cells were 
analyzed for GFP ﬂ  uorescence.  GFP-positive 
cells were scored for cell death by collapse of 
the mitochondrial membrane potential as de-
scribed previously ( Davalos and Campisi, 2003 ). 
200 GFP-positive cells were scored in two or three 
independent experiments for each transfection. 
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TIN2 depletion). Thus, additional events, such as cell cycle 
progression, chromosome fusion, and anaphase bridge forma-
tion might be necessary for the death of cells with lesions that 
inactivate p53 and complex B. To test this idea, we expressed 
GFP (control), TIN2-13, or TIN2-15C in HCA2 cells in which 
p53 was inactivated by GSE-22. Cells expressing TIN2-15C 
  Chromosomal abnormalities induced by 
TIN2 mutants 
 Although p53-defi  cient cancer cells underwent rapid cell death 
in response to TIN2-15C, p53 inactivation and TIN2-15C ex-
pression did not cause rapid cell death in presenescent or se-
nescent normal human fi  broblasts (in contrast to the effect of 
  Figure 5.       Effects of TIN2 mutants in normal cells.   (a) TIN2-15C suppresses proliferation of normal cells. We infected presenescent HCA2 cells with lenti-
viruses expressing GFP, wild-type (wt) TIN2, TIN2-13, or TIN2-15C and determined the cell number the indicated number of days thereafter. Plotted are 
cumulative cell numbers versus days in culture. (b) TIN2-15C induces cellular senescence. HCA2 cells were infected with lenti-GFP or lenti-TIN2-15C and 
assessed 10 d later for senescence-associated     -galactosidase as described previously (  Dimri et al., 1995  ). Replicatively senescent HCA2 cells were used 
as positive controls. Bars,     10   μ  m. (c) TIN2-13 and TIN2-15C induce damage foci in presenescent and senescent cells. Presenescent (P) and senescent (S) 
HCA2 cells were infected with lenti-TIN2-13 or lenti-TIN2-15C and stained 48 h later for expression of the mutant proteins and     H2AX or 53BP1 foci. 
50  –  80 cells were scored in two or three independent experiments for each transfection. Error bars represent the standard deviation.     JCB • VOLUME 181 • NUMBER 3 • 2008  456
TRF1, which suggests that TRF1 is not required for the TIN2  –
  TRF2/hRap1  –  TPP1/POT1 interaction (  Houghtaling et al., 2004  ). 
TRF1 and TRF2 bind noncooperatively along telomeric repeats 
and have high off-rates in vitro (  Bianchi et al., 1999  ). These 
results suggest that TIN2 may form dynamic TRF1 or TRF2 
complexes at telomeres. We identifi  ed three major soluble TIN2 
complexes (TRF1 – TIN2,  complex  A;  TIN2 – TRF2/hRap1 – TPP1/
POT1, complex B; and TRF1 – TIN2 – TRF2/hRap1 – TPP1/POT1, 
complex C) from nuclear extracts containing endogenously ex-
pressed proteins, which supports the idea that TRF1 and TRF2 
complexes are separable. 
  Previously reports (  Liu et al., 2004a  ;   Ye et al., 2004a  ) did 
not detect complex A, which suggests that our nuclear extrac-
tion protocol, which used higher salt concentrations, was more 
effective at dissociating TRF1  –  TIN2 complexes from telomeres 
or the nuclear matrix. TRF1 cross-reactivity was detected as 
multiple bands in low molecular weight fractions, which is 
likely due to proteolysis after release from telomeres (  Chang 
et al., 2003  ) or the nuclear matrix (  Okabe et al., 2004  ). In addi-
tion, we did not detect complex C as a major complex in cells 
that overexpressed TRF1 and TIN2 and were extracted by 
physiological salt. Complex C formation may require telomeric 
DNA, t-loop formation, and/or posttranslational modifi  cations 
to TRF1 or matrix-associated TRF1. 
  We used two TIN2 mutants with distinct abilities to dis-
rupt the major TIN2 complexes (A and B). TIN2-13 affected 
the TRF1-TIN2 complex A, whereas TIN2-15C affected TRF2 
complexes. If the major telomeric complex was a single entity 
(complex C), TIN2-13 and TIN2-15C should disrupt this com-
plex similarly. However, our results are more consistent with the 
existence of two separable TIN2 complexes, which may have dif-
ferent functions in cells. 
  TIN2 complexes may function differently 
  In normal cells, telomeres shorten with each division, eventu-
ally causing senescence. TIN2-15C, which disrupts complex B, 
removes TRF2 from telomeres and induces DNA damage foci 
but TRF1 remains at telomeres (  Kim et al., 2004  ). DN-TRF2 
also removes TRF2 and induces DNA damage foci containing 
TRF1 (  Takai et al., 2003  ). Senescent cells with short telomeres 
and telomeric DNA damage foci frequently lack TRF2 but not 
TRF1 (  Herbig et al., 2004  ). Thus, short telomeres may prefer-
entially attract A complexes, and senescent cells may be un-
able form enough complex B (TIN2 – TRF2/hRap1 – TPP1/POT1) 
because TIN2 is bound primarily in A (TRF1  –  TIN2) com-
plexes. Alternatively, complexes A and B may have different 
had a signifi  cantly more chromosome fusions (0.85 per meta-
phase) and anaphase bridges or micronuclei (   21%)  com-
pared with cells expressing TIN2-13 (0.19 per metaphase and 
    6% anaphase bridges or micronuclei;   Table I   and Fig. S5, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200710028/DC1). 
We observed no chromosome fusions and     4% anaphase bridges 
or micronuclei in cells expressing GFP. Fluorescence in situ hy-
bridization with a telomeric probe showed that most of the fused 
chromosomes in TIN2-15C  –  expressing cells possessed a telo-
meric signal (0.68 per metaphase), which is indicative of telomeric 
uncapping and subsequent fusion. These fusions are similar in 
type and level to those reported for cells expressing DN-TRF2 
(  van Steensel et al., 1998  ;   Hockemeyer et al., 2005  ;   Yang et al., 
2005  ), which is consistent with fi  ndings that TIN2 and TRF2 
interact and that TIN2-15C reduces telomeric TRF2 (  Kim et al., 
2004  ). A small fraction of fusions lacked telomeric signal (0.16 
per metaphase), which is more common upon loss of POT1 
function (  Wu et al., 2006  ). These results suggest that TIN2-15C 
may cause the death of p53-defi  cient cells indirectly by driving 
chromosome fusions and mitotic catastrophe. 
  Telomerase does not rescue TIN2-15C 
lethality 
  Telomerase can rescue senescent cells in which p53 has been in-
activated from crisis caused by dysfunctional telomeres. To deter-
mine whether telomerase can similarly rescue p53-defi  cient 
senescent cells from the dysfunctional telomeres caused by TIN2-
15C, we coexpressed the telomerase catalytic subunit (hTERT) 
and TIN2-15C in senescent HCA2 cells in which p53 was inacti-
vated by GSE-22. Telomerase prevented the crisis that limits the 
proliferative capacity of these cells to     20 population doublings 
(  Beausejour et al., 2003  ). However, coexpression of telomerase 
and TIN2-15C did not rescue the cells from loss of proliferative 
potential (  Fig. 6, a and b  ). These results suggest that TIN2-15C 
causes cell death by disrupting telomeric structure and capping 
rather than by shortening telomere length. 
  Discussion 
  TIN2 telomeric complexes 
 Six  telomere-associated  proteins  (TRF1 – TIN2 – TPP1 – POT1 –
  TRF2  –  hRAP1) have been isolated as a single soluble complex 
(  Liu et al., 2004a  ;   Ye et al., 2004a  ). TIN2 occupies a unique po-
sition in this complex because it interacts directly with TRF1 
and TRF2 and indirectly (through TPP1) with POT1. In these 
studies, TRF2 complexes contained TIN2 and POT1 but not 
  Table I.       Telomeric fusions caused by expression of TIN2 mutants   
Lentiviral vector No. metaphases analyzed No. chromosome fusions Fusions per metaphase Fusions per chromosome
+Tel    –  Tel
GFP 53 0 0 0 0
TIN2-13 53 7 3 0.18 0.0034
TIN2-15C 61 42 10 0.85 0.0175
Presenescent HCA2 cells were infected with a retroviruses expressing GSE-22, selected, and infected with lentiviruses expressing GFP, TIN2-13, or TIN2-15C. The cells 
were treated with colcemid, and telomeres on metaphase chromosomes were identiﬁ  ed by PNA-FISH as described in Materials and methods. Chromosome fusions 
were scored by ﬂ  uorescence in situ hybridization for the presence (+Tel) or absence (    Tel) of telomeric DNA at the site of fusion.457 TELOMERE COMPLEXES AND CELL SURVIVAL   •   Kim et al.
plexes modulate the telomeric tertiary structure and enhance the 
stability and function of complex B. Although TIN2-13 induces 
some telomere uncapping and telomeric fusion, the effects of 
TIN2-13 are less pronounced than those of TIN2-15C, which 
suggests that complex A supports the functions of complex B. 
  Alternatively, complexes A and B may cooperate to form 
the six-protein complex C (also termed shelterin;   de Lange, 
2005  ), and this complex may be the essential entity for telomere 
capping and cell survival. TIN2-13 may be less effi  cient than 
TIN2-15C at disrupting complex C. TPP1 may be an important 
regulator of complex C formation because loss of TPP1 can re-
duce  the  TRF1 – TRF2 – Rap1  interaction  ( O ’ Connor  et  al.,  2006 ). 
  Telomere-dependent cell survival in cells 
with or without p53 function 
  Late generation mice lacking both telomerase and p53 have 
a higher incidence of cancer relative to animals lacking only 
preferred locations on the telomere or t-loop and cooperate in 
telomere capping. 
 TRF1 – TIN2  complexes  stimulate  interactions  between 
telomeric DNA tracts in vitro, which suggests that this complex 
modulates a tertiary telomeric structure ( Kim et al., 2003 ). TIN2-13, 
which disrupts this complex (complex A), may decrease the 
complexity of the telomeric structure. However, deletion of TRF2 
or POT1 causes telomere uncapping and chromosome fusion, 
which suggests that complex B is essential for telomere end pro-
tection (  Hockemeyer et al., 2006  ;   Wu et al., 2006  ). Consistent with 
this view, we found that TIN2-15C, which disrupts complex B, 
uncapped telomeres and caused telomeric fusions and anaphase 
bridges. Thus, we favor the hypothesis that TRF1  –  TIN2 (A) 
complexes  and  TIN2 – TRF2/hRap1 – TPP1/POT1  (B)  complexes 
have different locations at telomeres and cooperate to form the 
telomeric cap (  Fig. 6 c  ). B complexes are more important for en-
suring a proper terminal or t-loop structure, whereas A com-
  Figure 6.       Effects of telomerase and a pro-
posed model.   (a) Telomerase does not rescue 
cell death by TIN2-15C. 5   ×   10 
4   senescent 
cells were infected with lentiviruses expressing 
GFP (control), the telomerase catalytic sub-
unit hTERT, TIN2-15C, or both TIN2-15C and 
hTERT. The cells were then infected with lenti-
GSE-22. After 2 d, the cells were subcultured 
and plated for colony formation. Colonies 
were ﬁ  xed and stained 61 d later. (b) Colonies 
were counted 5, 11, and 61 d after plating. 
Colonies were scored in two or three indepen-
dent experiments for each transfection. Error 
bars represent the standard deviation. (c) Pro-
posed model for TIN2 complexes at telomeres. 
Complex A and B cooperate, albeit at different 
positions on telomeres, to form t-loops or other 
terminal structures. Complex B may localize 
preferentially or uniquely near t-loop junctions, 
whereas A complexes may modulate the tertiary 
structure of telomeres and promote B complex 
stability. TIN2-13 disrupts complex A, thereby 
reducing the tertiary telomeric structure and de-
stabilizing B complexes, resulting in partial or 
mild disruption of t-loops and telomere uncap-
ping. TIN2-15C directly disrupts B complexes, 
resulting in severe disruption of t-loops and 
telomere uncapping. Cells expressing wild-
type p53 and TIN2-13 or TIN2-15 undergo 
growth arrest, whereas cells lacking functional 
p53 undergo cell death. In both cases, the 
consequences of TIN2-15C expression are 
more severe than that of expressing TIN-13.     JCB • VOLUME 181 • NUMBER 3 • 2008  458
  Materials and methods 
  Cell culture, senescence, and apoptosis characterization 
  We cultured all cells and measured senescence-associated     -galactosidase 
as described previously (  Dimri et al., 1995  ). We determined cell death by 
collapse of the mitochondrial membrane potential (  Davalos and Campisi, 
2003  ) or by a cumulative assay in which cells are incubated with a cas-
pase inhibitor for 3 d and scored for cytosolic cytochrome   c   (  Goldstein 
et al., 2005  ). 
  Separation of native TIN2 complexes 
  Nuclei were isolated from HeLa-S3 cell suspension cultures (20 liters, 10 
6   
cells per ml; National Cell Culture Center) and extracted with 0.5 M KCl 
by a modiﬁ  ed nuclear extraction method (  Dignam et al., 1983  ). Extracts 
were dialyzed into S-300 chromatography buffer (50 mM Tris, pH 7.5; 
150 mM KCl; 0.2 mM EDTA; 20% glycerol; 0.025% NP-40; 0.5 mM di-
thiothreitol; 1   μ  g/ml aprotinin, pepstatin A, and leupeptin; and 0.5 mM 
PMSF) and cleared by centrifugation at 15,000 rpm for 30 min at 4  °  C. 
The dialyzed sample (2.5 ml) was loaded onto a column (1.6/60 cm, 125 ml; 
Sephacryl S-300-HR; GE Healthcare) equilibrated with S-300 buffer. Frac-
tions (1.4 ml) were collected and stored at 4  °  C. The S-300 column was 
calibrated using molecular mass standards (blue dextran, thyroglobulin, 
ferretin, aldolase, and conalbumin; GE Healthcare) according to the manu-
facture  ’  s instructions. 
  We expressed Flag-tagged TIN2 and HA-tagged TRF1 in HT1080 
cells using the retroviral vector pLXSN as described previously (  Kim et al., 
1999  ). V5-tagged POT1 (a gift from P. Baumann, Stowers Institute of Medi-
cal Research, Kansas City, MO;   Baumann et al., 2002  ) and myc-TIN2 mu-
tants (TIN2-13 or TIN2-15C) were expressed using the pIRE2-EGFP vector 
(BD Biosciences) and transient transfection using Fugene 6 (Roche). 6   ×   10 
6   
cells were washed with PBS, and 1 ml RIPA buffer (50 mM Tris, pH 7.5, 
150 mM NaCl, 1% NP-40, 1 mM EDTA, 10% glycerol, and protease in-
hibitor cocktail; Roche) was added to each plate. After incubation on ice 
for 30 min, cells were collected by scraping and centrifugation at 4  °  C and 
the supernatant (cell lysate) was recovered. 
  Immunoprecipitation and western analyses 
  We incubated cell lysates (200  –  300   μ  g protein) with 2   μ  g HA antibody 
(Roche), 10   μ  g Flag M2 antibody (Sigma-Aldrich), or 2   μ  g V5 antibody 
(Invitrogen) for 2 h at 4  °  C and added 50   μ  l of a 50% protein G  –  Sepharose 
slurry (Invitrogen) for 2 h at 4  °  C. We washed the immune complexes with 
RIPA buffer and analyzed proteins by Western blotting as described previ-
ously (  Kim et al., 1999  ;   Davalos and Campisi, 2003  ). Primary antibodies 
were monoclonal anti-TRF2 (IMG-124A; Imgenex), polyclonal anti-hRap1 
(IMG-289; Imgenex), polyclonal anti-TRF1 (H-242 [Santa Cruz Biotechnol-
ogy, Inc.] and ab1423 [Abcam]), polyclonal anti-POT1 (H200; Santa 
Cruz Biotechnology, Inc.), polyclonal anti-HA or -TRF2 or monoclonal anti-
HA (Santa Cruz Biotechnology, Inc.), monoclonal anti-V5 (Invitrogen), 
polyclonal anti-TIN2 (  Kim et al., 1999  ), and polyclonal TPP1 (a gift from 
Z. Songyang, Baylor College of Medicine, Houston, TX;   O  ’  Connor et al., 
2006  ). The protein band intensities were analyzed by the Multi-Gauge 
program (Fujiﬁ  lm). 
  Immunostaining 
  We immunostained cells as described previously (  Kim et al., 1999  ). In brief, 
we cultured cells in chamber slides and cells were ﬁ  xed with 4% formalin, 
permeabilized with 0.5% Triton X-100, and stained with anti-TRF2, anti-
TIN2 (  Kim et al., 1999  ), polyclonal anti-53BP1 (Abcam), monoclonal anti-
p21 (BD Biosciences), monoclonal anti-p53 (Oncogene), or control (10% 
goat) serum (Vector Laboratories). After washing, we stained cells with sec-
ondary antibodies conjugated to Texas red or FITC (Invitrogen) and coun-
terstained the nuclei with DAPI. Images of cells were acquired on a 
microscope (BX60; Olympus) using either a 100  ×   UPlanFL 1.3 NA (Olym-
pus) lens with oil or a 40  ×   UPlanFL 0.5 NA (Olympus) lens without oil. 
Images were acquired with a charge-coupled device camera (Diagnostic 
Instruments, Inc.) and captured into SPOT imaging software (Diagnostic 
Instruments, Inc). All the modiﬁ  cations were applied to the whole image 
using Canvas 8 (Deneba) or Photoshop CS (Adobe). 
  Chromosome analyses 
  Telomeres were visualized by in situ hybridization (FISH) on metaphase 
spreads using a telomeric protein nucleic acid (PNA) probe as described 
previously (  Hultdin et al., 1998  ). Cells treated with 0.1   μ  g/ml colcemid for 
4 h were trypsinized and collected at 1,000   g   (5 min). After hypotonic 
swelling in 30 mM sodium-citrate for 20 min at 37  °  C, the cells were ﬁ  xed 
telomerase (  Chin et al., 1999  ), implicating p53 as a key regu-
lator of the response to telomere dysfunction. However, mice 
defi  cient in both p53 and telomerase lose sterility after only a 
few generations, which indicates a second p53-independent block 
to cell viability (  Chin et al., 1999  ). Expression of dominant-
negative telomerase proteins (  Hahn et al., 1999  ) or mutant 
telomerase RNAs (  Guiducci et al., 2001  ) induces death in 
cells with either wild-type or mutant p53, which supports the 
idea that the loss of viability caused by telomere dysfunction 
is not dependent on a functional p53 response. In contrast, cell 
death or growth inhibition caused by expression of DN-TRF2 
is p53 dependent (  Karlseder et al., 1999  ;   Smogorzewska and 
De Lange, 2002  ). 
  Our results indicate that complex B disruption by TIN2-
15C induces telomere dysfunction and cell cycle arrest in 
p53-positive cells. However, p53-deficient cells that express 
TIN2-15C continue to divide, developing chromosome-end 
fusions and anaphase bridges. These abnormalities result in cell 
death, which does not require p53 function. Thus, our fi  ndings 
support the idea that complex B disruption by TIN2-15C causes 
cell death that is independent of p53 due to severe genomic 
damage and mitotic catastrophe (  Fig. 6 c  ). Our results also sug-
gest that DN-TRF2 and TIN2-15C have different effects on the 
integrity of complex B. 
  In the absence of p53 activity, senescent cells that express 
little or no p16 can resume growth, although their proliferation 
is eventually limited by severe telomere shortening, crisis, and 
cell death (  Beausejour et al., 2003  ). Expression of telomerase 
eliminated this growth limitation. Expression of TIN2-13 and 
DN-TRF2 only minimally affected this growth resumption, 
whereas TIN2-15C expression accelerated this growth limitation. 
Recent fi  ndings ( Hockemeyer et al., 2005, 2006 ;  Wu et al., 2006 ) 
suggest an explanation for why the effects of TIN2-15C differ 
from those of DN-TRF2. Although POT1 defi  ciency causes a 
telomere uncapping phenotype similar to that caused by TRF2 
loss, POT1 and TRF2 likely have distinct functions in protect-
ing telomeres, regulating nucleolytic processing, and control-
ling telomeric recombination. Thus, TIN2-15C and DN-TRF2 
likely inactivate TRF2 and POT1 differently in complex B. 
Because DN-TRF2 induces p53-dependent apoptosis (  Karlseder 
et al., 1999  ), whereas TIN2-15C caused cell death in p53-
defi  cient cells, our fi  ndings offer an explanation for why ablation 
of TIN2 in cells (  Fig. 1  ) and in the mouse germ line (  Chiang 
et al., 2004  ) causes cell lethality or senescence regardless of 
p53 status. 
  It remains to be understood how telomere dysfunction 
causes cell death in p53-defi  cient cells, how dysfunctional 
telomeres are sensed as DNA damage, and the nature of 
the p53-dependent and -independent sensing mechanisms. 
Despite these gaps in our knowledge, telomerase inactivation 
has been proposed as an anticancer strategy because most can-
cer cells maintain telomere length by expressing this enzyme. 
Likewise, disruption of TIN2 complexes may provide a strat-
egy for preferential killing of cancer cells, most of which lack 
p53 function. Thus, TIN2-15C  –  sensitive complexes may pro-
vide a sensitive target for selective elimination of p53-defi  cient 
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in methanol/acetic acid (3:1). FISH using a Cy3-labeled (CCCTAA)  3   PNA 
probe (Applied Biosystem) and scoring for telomeric fusions were performed 
as described previously (  Bailey et al., 1999  ). 
  3    -G  –  rich strand overhangs were measured as described previously 
(  Kim et al., 1999  ). 4   μ  g of genomic DNA was hybridized with telomeric 
C-stranded probes (CCCTAA)  5   in nondenaturing buffer to detect the 3     
overhang and in denaturing buffer to detect total telomeric DNA. DNA sig-
nals were quantiﬁ  ed with the Multi-Gauge program (FLA-7000). 
  shRNA and expression vectors 
  Where indicated, cells were infected with a retrovirus expressing GSE-22 
(  Gudkov et al., 1993  ) or a lentivirus expressing sh-p53 (  Nair et al., 2005  ), 
selected, and then transfected with expression vectors or infected with 
lenti  viruses as described previously (  Beausejour et al., 2003  ;   Kim et al., 
2004  ). To ablate TIN2 expression, we synthesized double-stranded DNAs 
to target the TIN2 mRNA (T2i-1, CAGGTGAAGCAGCTGTCAG; T2i-2, 
GGTCATATCTAATCCTGAG; and T2i-3, GTGGTGGTGGAGCTGATC) or 
SATB1, a nuclear protein that is not expressed in ﬁ  broblasts or HT1080 
cells (AACAGCTACTATTGCCACT). We cloned the DNA into the pSuper 
vector (  Brummelkamp et al., 2002  ) and transiently transfected packaging 
cells using FuGene6 (Roche). We cloned TIN2 mutants into the bicistronic 
pIRES2-EGFP (Clontech Laboratories, Inc.) or a pPRL-Sin18-lenti vector (  Dull 
et al., 1998  ). Lentiviruses were used at equivalent titers sufﬁ  cient to infect 
    80  –  90% of cells. 
  Colony formation assay 
  Senescent cells (  <  2% labeling index) were plated with 5   ×   10 
4   cells in 
6-well plates and infected with lentiviruses expressing GFP, TIN2-15C, 
TIN2-13, hTERT, or GSE-22 as described previously (  Beausejour et al., 2003  ). 
The cells were washed with PBS twice, ﬁ  xed, and stained with 0.1% crystal 
violet in 10% ethanol for 5 min at room temperature, washed with PBS, 
and dried. 
  Online supplemental material 
  Fig. S1 shows that TIN2 reduction decreases TRF1 and TRF2 foci in immuno-
staining. Fig. S2 presents additional fractionation of TRF1  –  TIN2 com-
plexes from HeLa cell nuclear lysate on a Superdex S-200 HR column 
and shows that nuclear extraction efﬁ  ciently liberates telomeric proteins 
in our extraction protocol. Fig. S3 presents telomeric G-strand overhangs 
and telomere length analyses in cells expressing TIN2-15C and DN-TRF2. 
Fig. S4 shows telomeric damage responses that are costained for telomeric 
DNA in cells expressing TIN2-13 or TIN2-15C. Fig. S5 shows telomeric 
fusions and anaphase bridges in cells expressing TIN2-15C. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200710028/DC1. 
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